Process View
Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte differentiation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of leukocyte differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| C1QA | complement component 1, q subcomponent, A chain | 0.998 | Human | |
| HLA-C | major histocompatibility complex, class I, C | 0.996 | Human | |
| B2M | beta-2-microglobulin | 0.986 | ||
| ZNF43 | zinc finger protein 43 | 0.985 | ||
| HLA-A | major histocompatibility complex, class I, A | 0.982 | Human | |
| HLA-B | major histocompatibility complex, class I, B | 0.974 | ||
| CD80 | CD80 molecule | 0.883 | ||
| IL4R | interleukin 4 receptor | 0.881 | Mouse | |
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.861 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.849 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.834 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.791 | Mouse | |
| HOXB5 | homeobox B5 | 0.787 | Human | |
| ZNF253 | zinc finger protein 253 | 0.776 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.731 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.726 | Human | |
| CD86 | CD86 molecule | 0.630 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.606 | ||
| ZNF675 | zinc finger protein 675 | 0.558 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.549 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.535 | ||
| ZNF273 | zinc finger protein 273 | 0.533 | Human | |
| NCOR2 | nuclear receptor corepressor 2 | 0.502 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.480 | Human | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.470 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.458 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.455 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.435 | ||
| RXRA | retinoid X receptor, alpha | 0.424 | ||
| HOXA10 | homeobox A10 | 0.409 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.403 | ||
| FSTL1 | follistatin-like 1 | 0.336 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.311 | Human | |
| CCND1 | cyclin D1 | 0.290 | ||
| EPOR | erythropoietin receptor | 0.290 | ||
| RUNX1 | runt-related transcription factor 1 | 0.268 | ||
| ZNF430 | zinc finger protein 430 | 0.255 | Human | |
| ZNF117 | zinc finger protein 117 | 0.252 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.208 | ||
| MDFI | MyoD family inhibitor | 0.207 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.198 | Human | |
| GRAP2 | GRB2-related adaptor protein 2 | 0.175 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.170 | Human | |
| HOXA7 | homeobox A7 | 0.169 | ||
| GHR | growth hormone receptor | 0.165 | ||
| ZNF91 | zinc finger protein 91 | 0.165 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.162 | ||
| TAPBP | TAP binding protein (tapasin) | 0.158 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.151 | Human | |
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.150 | ||
| HOXA5 | homeobox A5 | 0.150 | Human | |
| ZNF93 | zinc finger protein 93 | 0.149 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.145 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.139 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.132 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.132 | ||
| BMP2 | bone morphogenetic protein 2 | 0.131 | Human | |
| GAB1 | GRB2-associated binding protein 1 | 0.130 | ||
| ZNF254 | zinc finger protein 254 | 0.128 | Human | |
| CCL13 | chemokine (C-C motif) ligand 13 | 0.128 | Human | |
| ZNF708 | zinc finger protein 708 | 0.127 | Human | |
| C1QC | complement component 1, q subcomponent, C chain | 0.121 | ||
| HOXB3 | homeobox B3 | 0.117 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.115 | ||
| CD14 | CD14 molecule | 0.106 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.105 | Human | |
| HOXA11 | homeobox A11 | 0.104 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.102 | Human | |
| CCND3 | cyclin D3 | 0.100 | ||
| IL4 | interleukin 4 | 0.098 | Mouse | |
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.098 | ||
| TUBA1A | tubulin, alpha 1a | 0.095 | ||
| HOXB9 | homeobox B9 | 0.094 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.094 | ||
| TMEM176B | transmembrane protein 176B | 0.088 | ||
| RBBP4 | retinoblastoma binding protein 4 | 0.088 | ||
| ZNF85 | zinc finger protein 85 | 0.082 | Human | |
| IL2RG | interleukin 2 receptor, gamma | 0.081 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.079 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.078 | ||
| PINK1 | PTEN induced putative kinase 1 | 0.077 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.076 | ||
| ZNF680 | zinc finger protein 680 | 0.075 | Human | |
| SH3BP2 | SH3-domain binding protein 2 | 0.075 | ||
| RARA | retinoic acid receptor, alpha | 0.071 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.069 | Human | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.067 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.067 | Human | |
| HOXB6 | homeobox B6 | 0.067 | Human | |
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.066 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.063 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.059 | ||
| DDB1 | damage-specific DNA binding protein 1, 127kDa | 0.057 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.057 | Human | |
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.055 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.054 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.054 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.054 | ||
| HOXB7 | homeobox B7 | 0.054 | Human | |
| TYMP | thymidine phosphorylase | 0.051 | ||
| CD28 | CD28 molecule | 0.050 | Human | |
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.048 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.047 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.047 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.047 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.045 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.043 | Human | |
| ZNF92 | zinc finger protein 92 | 0.043 | Human | |
| SLAMF8 | SLAM family member 8 | 0.043 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.041 | ||
| IRF4 | interferon regulatory factor 4 | 0.041 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.040 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.040 | Rat | |
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.039 | ||
| NGFR | nerve growth factor receptor | 0.038 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.038 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.037 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.037 | ||
| HOXA2 | homeobox A2 | 0.037 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.037 | ||
| SMAD3 | SMAD family member 3 | 0.037 | ||
| ADAMTS10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 | 0.036 | ||
| INHBA | inhibin, beta A | 0.035 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.035 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.035 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.035 | ||
| CD33 | CD33 molecule | 0.033 | ||
| SMAD7 | SMAD family member 7 | 0.033 | ||
| HOXA4 | homeobox A4 | 0.033 | Human | |
| MED25 | mediator complex subunit 25 | 0.032 | ||
| GATA2 | GATA binding protein 2 | 0.032 | Mouse | |
| NLRP3 | NLR family, pyrin domain containing 3 | 0.032 | ||
| CD163 | CD163 molecule | 0.032 | ||
| NME4 | non-metastatic cells 4, protein expressed in | 0.031 | ||
| HOXC10 | homeobox C10 | 0.031 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.030 | Mouse | |
| ZNF107 | zinc finger protein 107 | 0.030 | ||
| MARCO | macrophage receptor with collagenous structure | 0.029 | ||
| HOXA6 | homeobox A6 | 0.029 | Human | |
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.029 | ||
| BMP4 | bone morphogenetic protein 4 | 0.029 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.029 | ||
| C2 | complement component 2 | 0.027 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.027 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.027 | ||
| TP73 | tumor protein p73 | 0.027 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.027 | ||
| BAD | BCL2-associated agonist of cell death | 0.026 | ||
| CCND2 | cyclin D2 | 0.026 | ||
| IRF8 | interferon regulatory factor 8 | 0.025 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.025 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.025 | ||
| PCDH9 | protocadherin 9 | 0.025 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.025 | Human | |
| FPR3 | formyl peptide receptor 3 | 0.025 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.025 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.025 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.024 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.024 | ||
| FST | follistatin | 0.024 | Human | |
| IFNG | interferon, gamma | 0.024 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.023 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.023 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.023 | ||
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 0.023 | Human | |
| DARC | Duffy blood group, chemokine receptor | 0.023 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.023 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.022 | ||
| CREBBP | CREB binding protein | 0.022 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.022 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.022 | ||
| NKG7 | natural killer cell group 7 sequence | 0.022 | ||
| HFE | hemochromatosis | 0.022 | Human | |
| EBI3 | Epstein-Barr virus induced 3 | 0.020 | ||
| VPRBP | Vpr (HIV-1) binding protein | 0.020 | ||
| ATXN3 | ataxin 3 | 0.020 | ||
| SPIN1 | spindlin 1 | 0.020 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.020 | Human | |
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.020 | ||
| HIC1 | hypermethylated in cancer 1 | 0.019 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.019 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.019 | ||
| ZNF136 | zinc finger protein 136 | 0.019 | ||
| PGR | progesterone receptor | 0.019 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.019 | ||
| SMAD6 | SMAD family member 6 | 0.019 | ||
| HK3 | hexokinase 3 (white cell) | 0.019 | ||
| C1S | complement component 1, s subcomponent | 0.019 | ||
| ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 0.018 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.018 | ||
| TNF | tumor necrosis factor | 0.018 | ||
| RUNX2 | runt-related transcription factor 2 | 0.018 | Human | |
| KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | 0.018 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.018 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.018 | ||
| ANKRD12 | ankyrin repeat domain 12 | 0.018 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.017 | Zebrafish | |
| CCR4 | chemokine (C-C motif) receptor 4 | 0.017 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.017 | ||
| SNX9 | sorting nexin 9 | 0.017 | ||
| PLEK | pleckstrin | 0.017 | ||
| CH25H | cholesterol 25-hydroxylase | 0.017 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.016 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.016 | ||
| HCK | hemopoietic cell kinase | 0.016 | ||
| ZNF644 | zinc finger protein 644 | 0.016 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.016 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.016 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.016 | ||
| AR | androgen receptor | 0.016 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.016 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.016 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.016 | ||
| STAB1 | stabilin 1 | 0.016 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.015 | ||
| CMIP | c-Maf-inducing protein | 0.015 | ||
| HOXB8 | homeobox B8 | 0.015 | Human | |
| SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0.015 | ||
| RBAK | RB-associated KRAB zinc finger | 0.015 | ||
| APOE | apolipoprotein E | 0.015 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.015 | ||
| HOXC6 | homeobox C6 | 0.015 | Human | |
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.015 | ||
| HDAC5 | histone deacetylase 5 | 0.015 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.015 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.015 | ||
| CD84 | CD84 molecule | 0.015 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.015 | Human | |
| ESR1 | estrogen receptor 1 | 0.014 | ||
| ZNF682 | zinc finger protein 682 | 0.014 | Human | |
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.014 | ||
| ITGB1BP2 | integrin beta 1 binding protein (melusin) 2 | 0.014 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.014 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.014 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.014 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.014 | ||
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.014 | ||
| NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.014 | ||
| PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.014 | ||
| HOXA3 | homeobox A3 | 0.014 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.014 | ||
| LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 0.014 | ||
| CD83 | CD83 molecule | 0.013 | ||
| CAMK2D | calcium/calmodulin-dependent protein kinase II delta | 0.013 | ||
| HOXA1 | homeobox A1 | 0.013 | ||
| CUL1 | cullin 1 | 0.013 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.013 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.013 | ||
| TP53 | tumor protein p53 | 0.013 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.013 | ||
| CTSB | cathepsin B | 0.013 | ||
| SIRPA | signal-regulatory protein alpha | 0.013 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.013 | ||
| MAX | MYC associated factor X | 0.013 | ||
| SLAMF7 | SLAM family member 7 | 0.013 | ||
| HOXC9 | homeobox C9 | 0.013 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.013 | ||
| HDAC9 | histone deacetylase 9 | 0.013 | ||
| IFNA4 | interferon, alpha 4 | 0.013 | ||
| DCUN1D2 | DCN1, defective in cullin neddylation 1, domain containing 2 (S. cerevisiae) | 0.013 | ||
| POU2F2 | POU class 2 homeobox 2 | 0.013 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.012 | ||
| SELE | selectin E | 0.012 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.012 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.012 | Human | |
| C3 | complement component 3 | 0.012 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.012 | ||
| EP300 | E1A binding protein p300 | 0.012 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.012 | ||
| IL13 | interleukin 13 | 0.012 | ||
| ZNF100 | zinc finger protein 100 | 0.012 | Human | |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.012 | ||
| ROS1 | c-ros oncogene 1 , receptor tyrosine kinase | 0.012 | ||
| HOXC5 | homeobox C5 | 0.012 | Human | |
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.012 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.012 | ||
| APOC1 | apolipoprotein C-I | 0.012 | ||
| ITGA1 | integrin, alpha 1 | 0.012 | ||
| GFI1 | growth factor independent 1 transcription repressor | 0.012 | ||
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.012 | Human | |
| HOXC11 | homeobox C11 | 0.012 | ||
| IRF9 | interferon regulatory factor 9 | 0.012 | ||
| HOXD9 | homeobox D9 | 0.012 | ||
| NME3 | non-metastatic cells 3, protein expressed in | 0.011 | ||
| XCL1 | chemokine (C motif) ligand 1 | 0.011 | Human | |
| IGL@ | immunoglobulin lambda locus | 0.011 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.011 | ||
| SOCS2 | suppressor of cytokine signaling 2 | 0.011 | ||
| HOXD8 | homeobox D8 | 0.011 | Human | |
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.011 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.011 | ||
| ZNF138 | zinc finger protein 138 | 0.011 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.011 | ||
| SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.011 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.011 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.011 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.011 | ||
| IFNA21 | interferon, alpha 21 | 0.011 | Human | |
| MSC | musculin | 0.011 | ||
| CD209 | CD209 molecule | 0.011 | ||
| FMNL1 | formin-like 1 | 0.011 | ||
| HOXD12 | homeobox D12 | 0.011 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.011 | ||
| C1R | complement component 1, r subcomponent | 0.011 | ||
| ABHD16A | abhydrolase domain containing 16A | 0.010 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.010 | Human | |
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.010 | ||
| PRKD2 | protein kinase D2 | 0.010 | ||
| HOXC8 | homeobox C8 | 0.010 | Human | |
| TUBB3 | tubulin, beta 3 | 0.010 | ||
| CCBP2 | chemokine binding protein 2 | 0.010 | ||
| IRF5 | interferon regulatory factor 5 | 0.010 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.010 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.010 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.010 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.010 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.010 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.010 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.010 |